Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 2,352

Document Document Title
WO/1986/004503A1
A pharmaceutical composition, comprising: Coenzyme Q10 (ubidecarenone) 2-17% by weight; Lecithin 50-70% by weight; Surfactant agent 20-48% by weight. The surfactant agent has a melting point comprised between 35 and 55oC and a HLB value ...  
WO/1986/004058A1
Quinone derivatives represented by general formula (I), wherein R1 and R2 may be the same or different and each represents hydrogen, methyl or methoxy or, when taken together, R1 and R2 represent -CH=CH-CH=CH-, R3 represents hydrogen or ...  
WO/1986/000887A1
Quinone derivatives represented by general formula (I) wherein R1 and R2 may be the same or different, and each represents hydrogen, methyl or methoxy or, when taken together, R1 and R2 represent -CH=CH-CH=CH-, R3 represents hydrogen or ...  
WO/1985/001726A1
A compound of formula II and tautomeric forms thereof wherein: R1 - R4 are H, alkyl, aryl, alkaryl, halogen, hydroxy, alkoxy, aryloxy, aralkoxy, acyloxy, amino or alkylamino; R8 has the same meaning as given to R1 - R4 or may be glycosyl...  
WO/1984/004300A1
A process for removing unalkylated anthraquinones from alkylated anthraquinone by forming a solution thereof, reducing the solution sufficiently so that at least part of the unalkylated anthraquinone is in the reduced form and extracting...  
WO/1982/003625A1
An inactivation of the catalytic system easily occurs during the oxidation of reactive aromatics by means of molecular oxygen, in a carboxylic acid solution and in presence of a catalyst which, consists itself of a cobalt compound with o...  
WO/1981/002797A1
Phenolic and naphtholic compounds have been found to be useful as dye forming developers in photographic silver halide constructions. The dye forming developers form dye images upon oxidation and do not require the presence of couplers i...  
WO/1981/002574A1
1, 4-naphthoquinone derivatives represented by the following general formula: (FORMULA) (wherein R1 represents a hydrogen atom, a hydroxy group, a lower alkoxy group or an arylthio group, R2 represents a carboxy group, an esterified carb...  
WO/1980/000340A1
In a process for purifying naphthoquinone obtained by gas phase catalytic oxidation of naphthalene, the improvement which comprises contacting a solution of the naphthoquinone dissolved in a solvent capable of dissolving naphthoquinone a...  
JPWO2016199789A1
多様な機能性トリフルオロメチル化合物を製 造するために、トリフルオロメチル置換セミ スクアレートを短工程かつ効率的に合成する ことを課題とする。スクアレートを出発...  
JP6271415B2  
JP6266674B2  
JP2018002736A
[Subject] Freed Reich dysfunction syndrome; the Labor heredity optic nerve disorder; provide an effective cure for mitochondria obstacles, such as mitochondrial encephalomyopathy (MELAS) ; accompanied by lactic acidosis and apoplexy-like...  
JP6259410B2  
JP2017218387A
[Subject] Offer of a method of controlling disassembly of a dihydroxybenzene system compound in inside of a basin system fluid. [Means for Solution] A decomposition inhibition method of a dihydroxybenzene system compound are a decomposit...  
JP2017211667A
[Subject] One embodiment of the present invention aims at providing a photo conductor which can control generating of a picture Japanese quince even if it uses it for a long period of time. [Means for Solution] An electric charge transpo...  
JP2017210434A
[Subject] Offer of a compound which controls generating of a white point in a formation picture when contained in a photosensitive layer of an electrophotographic photoreceptor. [Means for Solution] A Naphthone quinone compound denoted b...  
JP2017178795A
[Subject] Offer of a new compound in which electric charge transportation ability used for an electrophotographic photoreceptor etc. is shown. [Means for Solution] A compound which has the structure denoted by a general formula (C1). (Ra...  
JP2017155017A
[Subject] An object of the present invention is to provide a method that oxidation reaction output of the hydrocarbon or its derivative can be manufactured efficiently by using hydrocarbon or its derivative as materials. [Means for Solut...  
JP6187980B2  
JP2017515900A
In this specification, the compound of (I), its salt which can be permitted pharmacologically, solvent Japanese food , a hydrate, many forms, cocrystal, a tautomerism object, a stereoisomeric form, and a prodrug are provided. Being provi...  
JP2017513810A
The present invention relates to the new can Navigator roll quinone derivative of formula (I), Or [that the inside of a formula and R are the carbon atoms of the basis of the straight chain expressed by an aryl group, an alkenyl group, a...  
JP2017061579A
[Subject] How to generate alpha Tocotrienol quinone or its stereoisomeric form is provided. [Means for Solution] It is the method of generating alpha Tocotrienol quinone or its stereoisomeric form, It includes making this method Ring ope...  
JP2016513122A5  
JP2017039678A
[Subject] Quantity yield and a method of producing cheaply are provided for 2-hydroxy 1 and 4-naphth quinone in large quantities. [Means for Solution] Under vanadium catalyst existence, 2-hydroxy Naphthalene is oxidized with hydrogen per...  
JP6080281B1
[Subject] An object of the present invention is to provide a method that oxidation reaction output of the hydrocarbon or its derivative can be manufactured efficiently by using hydrocarbon or its derivative as materials. [Means for Solut...  
JPWO2014103321A1
[Subject] The present invention makes it a subject to provide new pyruvic-acid-dehydrogenase inhibitor. [Means for Solution] Pyruvic-acid-dehydrogenase inhibitor which contains a compound denoted by general formula (I) as an active ingre...  
JP2017001971A
[Subject] Offer of a polymerization inhibition method of a vinyl aromatic monomer whose polymerization control effect improved. [Means for Solution] In 1 or a plurality of embodiments, it is related with a method of controlling a polymer...  
JP2017001970A
[Subject] Offer of a polymerization inhibition method of a vinyl aromatic monomer whose polymerization control effect improved. [Means for Solution] In 1 or a plurality of embodiments, it manufactures and a vinyl aromatic monomer refines...  
JP2016225431A
[Subject] An optical electromotive force element which charge separation tends to produce and electric charge re-combination does not produce easily is provided. [Means for Solution] It is an optical electromotive force element containin...  
JP2015533794A5  
JP2016526549A
Under existence of the catalyst or catalyst system for which the present invention contains at least one sort of copper halide (II) s among the reaction medium of the following step:2 phases or many phases, It is a step which obtains the...  
JP5969616B2  
JPWO2014038220A1
The present invention is a polymer metal complex in which at least Distribution which has two or more ligating property parts contains a metal ion as a child and a central metal, At least the Distribution has the three-dimensional networ...  
JP2016106542A
[Subject] It aims at providing a screening method for a substance which has anticancer (tumor) activity and/or antiviral activity which cut DNA specifically on a chromosome in which a DNA duplicate has occurred, or nucleic acid quickly a...  
JP5917458B2  
JP2016075739A
To provide a color filter coloring composition having high brightness and a high contrast ratio by solving three problems that are to impart solubility in organic solvents to a dye, to impart fastness to the dye, and to suppress fluoresc...  
JP2016513122A
This specification is provided with the process of preparing a useful cyclohex non compound for cancer disposal and/or a disease. This indication is related with composition and the process of preparing a cyclohex non compound. In one mo...  
JP2016065056A
[Subject] Offer of a constituent for treating any at least one of a partial state relevant to aging, a pimple, partial bacterial infection, partial fungus infection, and partial virus infection. [Means for Solution] (a) Ekino chromium A ...  
JP2016047854A
To provide a method for treating a mitochondrial disorder, adjusting one or more energy biomarkers, normalizing one or more energy biomarkers, or strengthening one or more energy biomarkers.Disclosed are not only the treatment method or ...  
JP2016509573A
The present invention relates to the tocopheryl quinone derivative and tocopherol derivative which the pharmacokinetics in in vivo has improved and which were improved, and it sets it to some embodiments, The tocopheryl quinone derivativ...  
JP2016034979A
To provide (hetero)aryl-p-quinone derivatives for treatment of mitochondrial diseases.Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondria...  
JP2016029112A
To provide effective methods of treating mitochondrial disorders, such as: Friedreich's ataxia; Leber's hereditary optic neuropathy; mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS); and Kearns-Sayr...  
JP5860722B2  
JP2016006043A
To provide a novel compound that has an anti-trypanosome activity.Provided is a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. (Ris C1 to 10 alkoxy group or the like; Ris alkyl group, alkoxy group,...  
JP2015533794A
In order to deal with or control an oxidant stress obstacle including a mitochondria obstacle, an energy processing fall obstacle, a neurodegenerating disease, and the disease by aging, Or one sort or two or more sorts of energy biomarke...  
JP2015193663A
To provide dyeing of keratin materials using two colorless dye precursors, at least one of which contains a disulfide/thiol unit, the precursors reacting together chemically to form the color in situ.The process according to the inventio...  
JP2015531404A
Vitamin K2A の MK*7 type adjustment method is characterized by adding the ヘキサ pre nil chain of "all the transformer" arrangement to the mono-pre nil derivative of menadiol by "1+6" strategy. According to the present invention, in ...  
JP2015187169A
To provide processes for production, enrichment and/or isolation of pure α-tocotrienol.The invention discloses novel processes for production, enrichment and/or isolation of α-tocotrienol from a raw material source comprising at least ...  
JP2015168660A
To produce arylhydroquinones and arylquinones in mild conditions without using a rare metal catalyst.A method for producing arylhydroquinones by Michael addition of a an aryl compound with quinones in the presence of a catalyst. As the c...  

Matches 301 - 350 out of 2,352